Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acer Therapeutics Inc. (ACER)

3.85   0.99 (34.62%) 01-17 16:44
Open: 3.01 Pre. Close: 2.86
High: 4.43 Low: 2.73
Volume: 19,880,434 Market Cap: 47M
Acer Therapeutics, Inc. is a pharmaceutical company. The company is headquartered in Newton, Massachusetts and currently employs 23 full-time employees. The firm is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The firm is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The firm is developing ACER-001, a pharmacologic treatment option for the treatment of Maple Syrup Urine Disease (MSUD). ACER-001 is an immediate-release formulation of sodium phenylbutyrate (NaPB) developed using a microencapsulation process. The firm is also developing ACER-001 for the treatment of Urea Cycle Disorders (UCD).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.433 - 4.454 4.454 - 4.474
Low: 2.696 - 2.711 2.711 - 2.726
Close: 3.815 - 3.849 3.849 - 3.88

Technical analysis

as of: 2021-01-15 4:37:12 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.17     One year: 6.04
Support: Support1: 3.11    Support2: 2.30
Resistance: Resistance1: 4.43    Resistance2: 5.17
Pivot: 2.68
Moving Average: MA(5): 2.93     MA(20): 2.66
MA(100): 2.66     MA(250): 3.04
MACD: MACD(12,26): 0.12     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 52.29     %D(3): 44.98
RSI: RSI(14): 81.06
52-week: High: 7.25  Low: 1.08  Change(%): -14.1
Average Vol(K): 3-Month: 58184  10-Days: 283207

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ACER has closed above the upper band by 37.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 78.2% wider than normal. The large width of the bands suggest high volatility as compared to ACER's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Fri, 15 Jan 2021
Global Maple Syrup Urine Disease Treatment Market Enhancement Study by Acer Therapeutics Inc, HemoShear Therapeutics, LLC, Recordati SpA, Jo Mar Laboratories, Siddhi Vinayaka Spechem Private Limited - KSU | The Sentinel Newspaper

Fri, 15 Jan 2021
Is Acer Therapeutics Inc (ACER) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Fri, 15 Jan 2021
Genetic Modification Therapies Market New Business Experts Ideas By Casebia Therapeutics, Acer Therapeutics, Beam Therapeutics, Editas Medicine, Marcala Biotech, Orchard Therapeutics - Industry Today

Thu, 14 Jan 2021
Pre-market Movers In Healthcare Sector: ORGO, NK, APYX, BIOL, ATHE, ACER… - Nasdaq

Wed, 13 Jan 2021
Is Acer Therapeutics Inc (ACER) The Right Choice in Biotechnology? - InvestorsObserver

Tue, 12 Jan 2021
How Will the Market React to Acer Therapeutics Inc (ACER) Stock Getting a Bearish Rating - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12
Shares Float (M) 5
% Held by Insiders 25.21
% Held by Institutions 37.47
Shares Short (K) 416
Shares Short P. Month (K) 348

Stock Financials

EPS -2.073
EPS Est This Year -4.870
EPS Est Next Year
Book Value (p.s.) 0.880
Profit Margin
Operating Margin
Return on Assets (ttm) -66.7
Return on Equity (ttm) -130.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.770
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -1.86
PEG Ratio
Price to Book value 4.38
Price to Sales
Price to Cash Flow -2.76

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.